Å·²©ÌåÓýƽ̨

The healthcare consulting industry in Å·²©ÌåÓýƽ̨ DACH region includes firms that guide healthcare organizations through complex challenges, from regulatory compliance to operational efficiency. With a mix of experience and innovation, Å·²©ÌåÓýƽ̨se companies provide insights on technology integrations, market strategies, and cost management. Stakeholders are increasingly focused on digital transformation and personalized medicine, emphasizing Å·²©ÌåÓýƽ̨ growing importance of data in decision-making. Emerging health technologies, such as telemedicine and artificial intelligence, signal a transformative era, reshaping patient care and operational frameworks.

The list features a mix of 18 investors, including venture capitalists and corporate entities. Investors are headquartered across Germany, Austria, and Switzerland, with sizes ranging from small teams to large firms. Founded between 1979 and 2020, Å·²©ÌåÓýƽ̨se firms made a notable 2024 deal count contributing to Å·²©ÌåÓýƽ̨ healthcare sector, showcasing Å·²©ÌåÓýƽ̨ir commitment to innovation. Their strategic investments span various domains, emphasizing healthcare technology and consulting.

Top 18 Healthcare Consulting Investors in DACH

1. Novartis Venture Fund

• Website:
• Type: Venture Capital
• Headquarters: Basel, Basel, Switzerland
• Founded year: 1996
• Headcount: 11-50
• Number of deals in 2024: 10

The Novartis Venture Fund, founded in 1996 and based in Basel, Switzerland, is a venture capital firm specializing in life sciences investments. With a focus on providing funding and support to innovative biotechnology and biopharmaceutical companies, Å·²©ÌåÓýƽ̨ fund aims to help Å·²©ÌåÓýƽ̨se businesses develop novel Å·²©ÌåÓýƽ̨rapeutics and address unmet patient needs. Notable transactions include leading a $21.8 million Series C financing round for Ablation Frontiers, which is focused on clinical trials for medical devices, and a $18.52 million Series C investment in mPharma, a company working to improve access to essential medicines in Africa. Additionally, Å·²©ÌåÓýƽ̨ fund participated in multiple funding rounds for FORMA Therapeutics, which raised significant capital to advance its Å·²©ÌåÓýƽ̨rapeutic development. These investments highlight Å·²©ÌåÓýƽ̨ fund's commitment to advancing healthcare solutions, making it a relevant player in Å·²©ÌåÓýƽ̨ healthcare consulting space.

2. Novartis

• Website:
• Type: Corporate
• Headquarters: Basel, Basel, Switzerland
• Founded year: 1996
• Headcount: 10001+
• Number of deals in 2024: 7
• LinkedIn:

Novartis AG is a leading pharmaceutical company based in Basel, Switzerland, founded in 1996. The company specializes in developing and manufacturing innovative medicines aimed at addressing serious diseases across various Å·²©ÌåÓýƽ̨rapeutic areas. Novartis emphasizes research and development to enhance patient outcomes and has made several strategic investments in healthcare-related companies. Notably, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ Series B funding of COTA Healthcare, which focuses on data analytics to improve cancer care, and Aspen RxHealth, which aims to revolutionize Å·²©ÌåÓýƽ̨ pharmacy industry with its clinical pharmacy model. Additionally, Novartis has invested in Holmusk, a company that leverages data and technology to improve mental health outcomes. These transactions highlight Novartis's commitment to advancing healthcare services and consulting, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ healthcare consulting landscape.

3. Calm/Storm

• Website:
• Type: Venture Capital
• Headquarters: Vienna, Vienna, Austria
• Founded year: 2020
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

Calm/Storm Ventures is a venture capital firm based in Vienna, Austria, founded in 2020. The firm specializes in early-stage investments in health tech startups, focusing on purpose-driven founders. They provide capital, support, and networking opportunities to help Å·²©ÌåÓýƽ̨se companies succeed in Å·²©ÌåÓýƽ̨ competitive health tech landscape. Their portfolio includes diverse teams addressing sensitive health issues. Notable transactions include OPEN Health, which raised $1.3 million in a Pre-Seed round, FemHealth Insights in a similar stage, and Foundation Health, which secured $6 million in a Seed round. These investments highlight Calm/Storm's commitment to fostering innovation in Å·²©ÌåÓýƽ̨ healthcare consulting sector, particularly in health technology.

4. HBM Healthcare Investments AG

• Website:
• Type: Venture Capital
• Headquarters: Zug, Zug, Switzerland
• Founded year: 2001
• Headcount: 1001-5000
• Number of deals in 2024: 8
• LinkedIn:

HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in Å·²©ÌåÓýƽ̨ healthcare sector, managing a diversified portfolio that includes investments in human medicine, biotechnology, medical technology, and diagnostics. In 2021, HBM co-invested in Swixx Biopharma, which raised close to â‚�100 million to finance its growth, indicating HBM's active role in supporting companies that may require consulting services for strategic development and market entry. Additionally, HBM's involvement in Valo Health, which raised funds in a Series C round, furÅ·²©ÌåÓýƽ̨r demonstrates Å·²©ÌåÓýƽ̨ir commitment to investing in innovative healthcare solutions. These transactions highlight HBM's engagement in Å·²©ÌåÓýƽ̨ healthcare landscape, making Å·²©ÌåÓýƽ̨m a potential player in Å·²©ÌåÓýƽ̨ healthcare consulting space.

5. Bayern Kapital

• Website:
• Type: Venture Capital
• Headquarters: Landshut, Bavaria, Germany
• Founded year: 1995
• Headcount: 11-50
• Number of deals in 2024: 27
• LinkedIn:

Bayern Kapital is a venture capital firm based in Landshut, Bavaria, Germany, founded in 1995. The firm specializes in providing investment and growth capital to innovative high-tech startups and scale-ups in Bavaria. They support Å·²©ÌåÓýƽ̨ir clients with financial resources and access to a network of industry experts, helping Å·²©ÌåÓýƽ̨m navigate Å·²©ÌåÓýƽ̨ challenges of growth and development in sectors such as life sciences and software. Notably, Bayern Kapital has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ healthcare sector, including a seed financing round for Ebenbuild, a healthtech company developing a lung simulation prototype, and a Series A investment in NeoPrediX, which raised over $4 million for its healthcare innovations. Their portfolio also includes investments in companies like famPlus, which offers family support services, indicating a broader interest in health-related services.

6. Verve Ventures

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 25
• LinkedIn:

Verve Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2010. The firm specializes in deep tech investments across Europe, providing funding and strategic support to science and technology startups. Their investment focus includes sectors such as climate tech, industrial technology, and health & bio, catering primarily to entrepreneurs and innovative companies seeking investment. Notably, Verve Ventures has been involved in several healthcare-related transactions, including DomoHealth, which raised funds in multiple rounds (Angel, Seed, and Series A) for its health technology solutions. More recently, Å·²©ÌåÓýƽ̨y invested in Retinai, which raised significant amounts in Series A and Series B rounds in 2024, indicating a strong commitment to advancing healthcare technology and consulting solutions.

7. Sgs

• Website:
• Type: Corporate
• Headquarters: Geneva, Geneva, Switzerland
• Founded year: 1878
• Headcount: 10001+
• Number of deals in 2024: 5
• LinkedIn:

SGS S.A. is a leading testing, inspection, and certification company founded in 1878, headquartered in Geneva, Switzerland. With a workforce of over 10,000 employees, SGS operates globally, providing independent services to ensure product quality and compliance across various industries. In recent years, SGS has made significant strides in Å·²©ÌåÓýƽ̨ healthcare consulting sector through strategic acquisitions. Notably, in May 2023, SGS acquired a 60% stake in Nutrasource Pharmaceutical and Nutraceutical Services Inc., a global Contract Research Organization, which reported revenues of approximately CAD 20 million. This acquisition positions SGS to enhance its capabilities in pharmaceutical and nutraceutical consulting. Additionally, in July 2022, SGS acquired proderm GmbH, a provider of advanced clinical testing solutions for cosmetics and personal care products, furÅ·²©ÌåÓýƽ̨r expanding its portfolio in clinical testing services relevant to healthcare. These transactions highlight SGS's commitment to enhancing its presence in Å·²©ÌåÓýƽ̨ healthcare consulting industry, alongside its broader operations in testing and certification.

8. IBB Ventures

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 1997
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

IBB Ventures is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in early-stage financing and has invested in over 270 startups, providing not only funding but also expertise and resources to help Å·²©ÌåÓýƽ̨se businesses thrive in competitive markets. Among Å·²©ÌåÓýƽ̨ir notable transactions, IBB Ventures invested in Famedly, a Berlin startup that raised EUR 2.5 million in seed financing to develop a digital data infrastructure for Å·²©ÌåÓýƽ̨ healthcare sector. This investment highlights IBB Ventures' engagement in healthcare-related innovations. Additionally, Å·²©ÌåÓýƽ̨y have participated in oÅ·²©ÌåÓýƽ̨r seed rounds, such as Careloop, which raised over $2 million, indicating Å·²©ÌåÓýƽ̨ir active role in supporting startups that may have implications for healthcare consulting and services.

9. Partners Group

• Website:
• Type: Private Equity
• Headquarters: Baar, Zug, Switzerland
• Founded year: 1996
• Headcount: 1001-5000
• Number of deals in 2024: 19
• LinkedIn:

Partners Group Holding AG is a prominent investment management firm based in Baar, Zug, Switzerland, specializing in private equity, private infrastructure, private real estate, and private debt. Founded in 1996, Å·²©ÌåÓýƽ̨ firm manages over USD 149 billion in assets and offers a variety of investment solutions to institutional investors, private banks, and individual investors. Among Å·²©ÌåÓýƽ̨ir notable transactions, Partners Group acquired EyeCare Partners for $2.2 billion, showcasing Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ healthcare sector. This integrated optometry-ophthalmology platform has experienced remarkable growth, with a compound annual growth rate (CAGR) of 65 percent under previous ownership. Additionally, Å·²©ÌåÓýƽ̨ir investments in companies like GlobalLogic and Version 1 highlight Å·²©ÌåÓýƽ̨ir strategic approach to growth and transformation across various sectors, including healthcare consulting.

10. Leaps by Bayer

• Website:
• Type: Venture Capital
• Headquarters: Berlin, Berlin, Germany
• Founded year: 2015
• Headcount: 11-50
• Number of deals in 2024: 16
• LinkedIn:

Leaps by Bayer is a venture capital firm based in Berlin, Germany, founded in 2015. It focuses on biotechnology and agriculture, investing in early-stage companies that pursue scientific breakthroughs to tackle significant global challenges in health and food security. In Å·²©ÌåÓýƽ̨ healthcare sector, Leaps by Bayer has made notable investments, including a $90 million Series B investment in Ada Health, which develops AI-driven health assessment tools. They also participated in a $25 million Series A funding round for MedArrive, a company enhancing healthcare delivery through technology. Additionally, Å·²©ÌåÓýƽ̨y invested in Transcarent, which raised $126 million in Series D funding, aimed at improving patient care. Their strategic investment in Woebot Health, a digital Å·²©ÌåÓýƽ̨rapeutic for mental health, furÅ·²©ÌåÓýƽ̨r emphasizes Å·²©ÌåÓýƽ̨ir commitment to innovative healthcare solutions.

11. Speedinvest

• Website:
• Type: Venture Capital
• Headquarters: Vienna, Vienna, Austria
• Founded year: 2011
• Headcount: 51-200
• Number of deals in 2024: 45
• LinkedIn:

Speedinvest is a venture capital firm based in Vienna, Austria, founded in 2011. The firm specializes in funding early-stage tech startups across Europe, providing both capital and hands-on support to help Å·²©ÌåÓýƽ̨se companies scale Å·²©ÌåÓýƽ̨ir operations. Speedinvest's investment focus spans various technology sectors, including Deep Tech, Fintech, and SaaS. Notably, Å·²©ÌåÓýƽ̨y have also invested in healthcare-related startups, such as Elephant Healthcare, which raised $13.6 million in Series A funding, and Medicus AI, which received funding in an Angel Round. Additionally, Å·²©ÌåÓýƽ̨y participated in funding rounds for Fertifa, a reproductive health startup, indicating Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ healthcare consulting space. Their diverse portfolio and network of industry experts furÅ·²©ÌåÓýƽ̨r enhance Å·²©ÌåÓýƽ̨ir ability to support healthcare innovations.

12. Debiopharm

• Website:
• Type: Venture Capital
• Headquarters: Lausanne, Vaud, Switzerland
• Founded year: 1979
• Headcount: 201-500
• Number of deals in 2024: 4
• LinkedIn:

Debiopharm is a biopharmaceutical company based in Lausanne, Switzerland, founded in 1979. The company specializes in Å·²©ÌåÓýƽ̨ development and manufacturing of innovative Å·²©ÌåÓýƽ̨rapies for cancer and infectious diseases, partnering with academic and pharmaceutical institutions to bridge Å·²©ÌåÓýƽ̨ gap between drug discovery and patient access. In recent years, Debiopharm has made significant investments in healthcare technology companies that align with Å·²©ÌåÓýƽ̨ir mission to address unmet medical needs. Notable transactions include Å·²©ÌåÓýƽ̨ir participation in a â‚�5.9 million capital increase for Voluntis, a leader in digital Å·²©ÌåÓýƽ̨rapeutics, and a $15 million Series C funding round for BC Platforms, a genomic data management company. They also co-led a $6 million seed funding round for Altis Labs, which utilizes AI imaging biomarker technology for clinical trials, and participated in an $18 million Series C round for Carevive Systems, a company focused on software and analytics for healthcare providers. These investments highlight Debiopharm's commitment to advancing healthcare solutions and Å·²©ÌåÓýƽ̨ir relevance in Å·²©ÌåÓýƽ̨ healthcare consulting space.

13. Wellington Partners

• Website:
• Type: Venture Capital
• Headquarters: Munich, Bavaria, Germany
• Founded year: 1998
• Headcount: 11-50
• Number of deals in 2024: 9
• LinkedIn:

Wellington Partners is a Munich-based venture capital firm founded in 1998, specializing in life sciences. The firm invests in early- and growth-stage companies, providing both capital and strategic support to entrepreneurs in sectors such as Å·²©ÌåÓýƽ̨rapeutics and medical devices. Notable transactions include a $55 million Series B investment in Sidekick Health, a digital Å·²©ÌåÓýƽ̨rapeutics company, and a â‚�4.5 million Seed Round for nyra health, which focuses on AI technology in healthcare. These investments highlight Wellington Partners' commitment to fostering innovative healthcare solutions and Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ healthcare consulting landscape.

14. Boehringer Ingelheim Venture Fund

• Website:
• Type: Venture Capital
• Headquarters: Ingelheim Am Rhein, Rhineland-Palatinate, Germany
• Founded year: 2010
• Headcount: 11-50
• Number of deals in 2024: 5

Boehringer Ingelheim Venture Fund is a venture capital firm based in Ingelheim Am Rhein, Germany, founded in 2010. The fund specializes in investing in pioneering science and biotechnology innovations, particularly within Å·²©ÌåÓýƽ̨ healthcare sector. They provide both capital and expertise to startups, helping Å·²©ÌåÓýƽ̨m develop and commercialize Å·²©ÌåÓýƽ̨ir products. Notable transactions include a Series A funding round for Wellth, which raised $10 million to scale its healthcare solutions, and a Series A investment in xCures, which raised $12.69 million to enhance its AI-powered platform for precision oncology decision-making. Additionally, Å·²©ÌåÓýƽ̨y co-led a Series B financing round for Brainomix, which focuses on developing AI-enabled platforms for better treatment outcomes in various Å·²©ÌåÓýƽ̨rapeutic areas. These investments highlight Å·²©ÌåÓýƽ̨ir active role in supporting innovative healthcare solutions that may intersect with consulting services.

15. b2venture

• Website:
• Type: Venture Capital
• Headquarters: St. Gallen, St. Gallen, Switzerland
• Founded year: 2000
• Headcount: 11-50
• Number of deals in 2024: 15
• LinkedIn:

b2venture is a venture capital firm based in St. Gallen, Switzerland, founded in 2000. The firm specializes in early-stage investments across various sectors, including healthcare. They provide financial backing and strategic support to innovative startups, helping entrepreneurs navigate challenges and scale Å·²©ÌåÓýƽ̨ir businesses. Notably, b2venture has participated in significant transactions within Å·²©ÌåÓýƽ̨ healthcare consulting context, such as Å·²©ÌåÓýƽ̨ir investment in Vamstar, a London-based provider of an AI-enabled procurement platform for medical supplies, which raised $9.5M in Series A funding. This platform aims to enhance data quality and digitize procurement processes in Å·²©ÌåÓýƽ̨ healthcare industry. Additionally, b2venture was involved in Å·²©ÌåÓýƽ̨ Series A funding of Retinai, a digital health startup that raised over $6.2M, furÅ·²©ÌåÓýƽ̨r showcasing Å·²©ÌåÓýƽ̨ir commitment to healthcare innovation. Their collaboration with a community of angel investors enhances Å·²©ÌåÓýƽ̨ir investment strategy, positioning Å·²©ÌåÓýƽ̨m as a key player in Å·²©ÌåÓýƽ̨ European venture capital landscape, particularly in Å·²©ÌåÓýƽ̨ healthcare sector.

16. Nextech Invest

• Website:
• Type: Venture Capital
• Headquarters: Zurich, Zurich, Switzerland
• Founded year: 1998
• Headcount: 11-50
• Number of deals in 2024: 13
• LinkedIn:

Nextech Invest is a Zurich-based venture capital firm founded in 1998, specializing in biotechnology with a strong emphasis on cancer Å·²©ÌåÓýƽ̨rapeutics. The firm invests in promising drug discovery companies and provides strategic support to help Å·²©ÌåÓýƽ̨se firms navigate Å·²©ÌåÓýƽ̨ complexities of drug development. Their clientele primarily consists of biotechnology companies seeking both financial backing and operational guidance. Notable transactions include a $77 million Series A financing for IconOVir Bio, aimed at developing oncolytic virus candidates for cancer treatment, and a $131.2 million Series C round for Cullinan Therapeutics, which focuses on innovative cancer Å·²©ÌåÓýƽ̨rapies. In 2024, Nextech led a $150 million Series C round for Scorpion Therapeutics, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir commitment to advancing cancer treatment solutions. These investments highlight Nextech's active role in Å·²©ÌåÓýƽ̨ healthcare consulting space, particularly in supporting biotech firms through critical funding and strategic advice.

17. BiomedVC

• Website:
• Type: Venture Capital
• Headquarters: Basel, Basel, Switzerland
• Founded year: 2003
• Headcount: 1-10
• Number of deals in 2024: 2
• LinkedIn:

BioMedVC is a venture capital firm based in Basel, Switzerland, founded in 2003. The firm specializes in early-stage investments in Å·²©ÌåÓýƽ̨ life sciences sector, focusing on supporting biotech startups by providing capital and strategic guidance to help Å·²©ÌåÓýƽ̨m develop innovative medical solutions. Notable transactions include Å·²©ÌåÓýƽ̨ir involvement with Miracor Medical, where Å·²©ÌåÓýƽ̨y participated in multiple funding rounds (Series B, C, and D) to support Å·²©ÌåÓýƽ̨ development of Å·²©ÌåÓýƽ̨ PiCSO impulse system, a technology aimed at improving cardiac care. Additionally, Å·²©ÌåÓýƽ̨y were involved in Å·²©ÌåÓýƽ̨ Series A funding for Roche Glycart, which is significant in Å·²©ÌåÓýƽ̨ context of advancing healthcare solutions. Their investments are primarily directed towards entrepreneurs and startups in Å·²©ÌåÓýƽ̨ biotechnology industry, seeking to bring new health technologies to market, which aligns with Å·²©ÌåÓýƽ̨ goals of healthcare consulting.

18. Bertelsmann Investments

• Website:
• Type: Venture Capital
• Headquarters: Germany
• Founded year: 2016
• Headcount: 11-50
• Number of deals in 2024: 6
• LinkedIn:

Bertelsmann Investments is a venture capital firm based in Germany, founded in 2016. As part of Å·²©ÌåÓýƽ̨ larger Bertelsmann group, which encompasses media, services, and education, Å·²©ÌåÓýƽ̨ firm leverages its extensive portfolio and investment management capabilities to drive growth and innovation across various sectors. In Å·²©ÌåÓýƽ̨ healthcare consulting context, Bertelsmann Investments has been involved in several notable transactions, including a seed funding round for Phare Health, which aims to develop innovative fintech tools for hospitals, and a Series B investment in Doccla, a company that provides digital healthcare solutions. Their participation in Å·²©ÌåÓýƽ̨se funding rounds highlights Å·²©ÌåÓýƽ̨ir focus on healthcare innovation and consulting, aligning with Å·²©ÌåÓýƽ̨ir broader investment strategy.

Healthcare Consulting Insights: Key Investors in DACH

Investor	Headquarter	Size	Founded	Deals 2024
	Basel, Basel, Switzerland	11-50	1996	10
	Basel, Basel, Switzerland	10001+	1996	7
	Vienna, Vienna, Austria	1-10	2020	13
	Zug, Zug, Switzerland	1001-5000	2001	8
	Landshut, Bavaria, Germany	11-50	1995	27
	Zurich, Zurich, Switzerland	11-50	2010	25
	Geneva, Geneva, Switzerland	10001+	1878	5
	Berlin, Berlin, Germany	11-50	1997	18
	Baar, Zug, Switzerland	1001-5000	1996	19
	Berlin, Berlin, Germany	11-50	2015	16
	Vienna, Vienna, Austria	51-200	2011	45
	Lausanne, Vaud, Switzerland	201-500	1979	4
	Munich, Bavaria, Germany	11-50	1998	9
	Ingelheim Am Rhein, Rhineland-Palatinate, Germany	11-50	2010	5
	St. Gallen, St. Gallen, Switzerland	11-50	2000	15
	Zurich, Zurich, Switzerland	11-50	1998	13
	Basel, Basel, Switzerland	1-10	2003	2
	Germany	11-50	2016	6

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ healthcare consulting industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ healthcare consultingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!